tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Korro Bio Advances RNA Editing Programs in Q2 2025
PremiumCompany AnnouncementsKorro Bio Advances RNA Editing Programs in Q2 2025
2M ago
Korro Bio reports Q2 EPS ($2.74), consensus ($2.59)
Premium
The Fly
Korro Bio reports Q2 EPS ($2.74), consensus ($2.59)
2M ago
Buy Rating for Korro Bio Driven by Promising KRRO-110 and Orphan Drug Designation
Premium
Ratings
Buy Rating for Korro Bio Driven by Promising KRRO-110 and Orphan Drug Designation
3M ago
Korro Bio Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsKorro Bio Reports Q1 2025 Financial Results
5M ago
Korro Bio price target lowered to $53 from $130 at H.C. Wainwright
Premium
The Fly
Korro Bio price target lowered to $53 from $130 at H.C. Wainwright
5M ago
Korro Bio price target lowered to $100 from $115 at H.C. Wainwright
Premium
The Fly
Korro Bio price target lowered to $100 from $115 at H.C. Wainwright
5M ago
Korro Bio initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyKorro Bio initiated with an Overweight at Cantor Fitzgerald
6M ago
Korro Bio initiated with a Buy at Chardan
Premium
The Fly
Korro Bio initiated with a Buy at Chardan
6M ago
Korro Bio appoints Loic Vincent as Chief Scientific Officer
Premium
The Fly
Korro Bio appoints Loic Vincent as Chief Scientific Officer
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100